Home/News/Details

California Proposes to List Three PFAS on Proposition 65 Reproductive Toxicant List

Nov 16, 2026
USA
Favorites
Share
Unlock exclusive content and benefits? Sign up for free today!

On October 30, 2026, the Office of Environmental Health Hazard Assessment (OEHHA), under the California Environmental Protection Agency, issued three notices of intent to list perfluorohexanoic acid (PFHxA), perfluorodecanoic acid (PFDA), and perfluorobutanoic acid (PFBA), along with their related salts, on the California Proposition 65 Reproductive Toxicant List. The deadline for public comment is November 30, 2026.

1. Perfluorohexanoic Acid (PFHxA, CASRN 307-24-4) and Related Salts

Basis: U.S. EPA IRIS Toxicological Review published in 2023

Listing Rationale: OEHHA determined that it meets listing criteria, based on developmental toxicity endpoints

Key Findings:

  • EPA Conclusion: "PFHxA is likely to cause developmental effects in humans under exposure conditions sufficient to produce high exposure"
  • Animal studies (mice and rats) showed that oral exposure to PFHxA (≥100 mg/kg-day) resulted in decreased offspring body weight and increased mortality
  • Based on this, EPA developed chronic and subchronic oral reference doses (RfD = 5×10⁻⁴ mg/kg-day), with decreased body weight in neonatal rats as the point of departure

2. Perfluorodecanoic Acid (PFDA, CASRN 335-76-2) and Related Salts

Basis: U.S. EPA IRIS Toxicological Review published in 2024

Listing Rationale: OEHHA determined that it meets listing criteria, based on three endpoints: developmental toxicity, male reproductive toxicity, and female reproductive toxicity

Key Findings:

  • EPA Conclusion: "PFDA is likely to cause adverse effects on the liver, immune system, development, and male and female reproductive systems in humans"
  • Developmental toxicity: Decreased fetal body weight in mice with increasing dose (≥0.5 mg/kg-day); human epidemiological studies also showed decreased birth weight and length
  • Male reproductive toxicity: Changes in sperm count, testosterone levels, and reproductive tissue pathology in rats following exposure (≥0.625 mg/kg-day)
  • Female reproductive toxicity: Changes in uterine weight and estrous cycle in rats following exposure (≥1.25 mg/kg-day)
  • Based on this, EPA developed lifetime and subchronic oral reference doses (RfD = 2×10⁻⁹ mg/kg-day)

3. Perfluorobutanoic Acid (PFBA, CASRN 375-22-4) and Related Salts

Basis: U.S. EPA IRIS Toxicological Review published in 2022

Listing Rationale: OEHHA determined that it meets listing criteria, based on three endpoints: developmental toxicity, male reproductive toxicity, and female reproductive toxicity

Key Findings:

  • EPA Conclusion: "PFBA exposure is likely to cause developmental effects in humans," including increased prenatal effects and delayed developmental milestones (delayed eyelid opening, vaginal opening, and preputial separation)
  • Reproductive developmental delay: Delayed vaginal opening and preputial separation following embryonic exposure in mice
  • EPA developed a subchronic oral reference dose (RfD = 6×10⁻³ mg/kg-day), with developmental delay as the point of departure
  • Note: EPA considers the evidence regarding PFBA's reproductive toxicity in adults as "inadequate," but the evidence for developmental effects as "moderate"

Potential Impact

Under the provisions of California Proposition 65, any business operating in California that sells products, operates facilities, or releases substances containing listed chemicals, and where exposure exceeds the safe harbor level, must provide clear and reasonable warnings to inform consumers or workers that the substance may cause cancer or reproductive toxicity. Warnings may be provided through various means, such as: labeling consumer products, posting notices in the workplace, distributing notifications at rental housing complexes, or publishing announcements in newspapers. The requirement to provide warnings becomes effective one year after the chemical is listed.

Furthermore, the proposition explicitly prohibits businesses from knowingly and intentionally discharging listed chemicals into any waters that may become a source of drinking water while conducting operations in California. Within twenty months from the date of listing, businesses must implement discharge control measures to ensure full compliance with this prohibition.

If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.

GlobalCosing Copyright Disclaimers:

1. All texts, graphics, videos and audios with "Source: GlobalCosing" on this website are copyrighted by GlobalCosing. Without authorization, no media, website or individual is allowed to reproduce, link, distribute, publish, or copy any content in this website. Other media, website with our authorization shall indicate "Source: CIRS Group" when downloading or using relevant contents. Unauthorized actions will be persecuted.

2. Texts and graphics on thie website without "Source: GlobalCosing" are reproduced for further information but not imply the endorsement of views or autheticity of its content. Other media, websites or individuals download or use relevant content shall remain its "Source" as prescribed in this website and bear corresponding legal responsibilities. Any unauthorized alternation to "Source: GlobalCosing" may be persecuted. If you have any questions about relevant content on this website, please contact us.

3. If any content reproduced on GlobalCosing raises copyright or other related issues, please contact us within two weeks.

4. CAS and CAS Registry Number are registered trademarks of the American Chemical Society. Any reference to such identifiers is made solely for the purpose of identifying chemical substances. GlobalCosing is an independent platform and is not affiliated with, sponsored by, endorsed by, or an authorized partner of CAS or ACS. Based on CIRS’s current review, the identifiers displayed on this platform were not obtained directly from CAS REGISTRY or any CAS subscription product or service. They were collected from governmental regulatory publications and other independent third-party sources. Users should independently verify the information before relying on it.

Disclaimers
1.
CIRS aims to keep the content of this site accurate and up to date. However, CIRS makes no warranties or representations regarding the quality, accuracy, completeness or reliability of information on the site.
2.
In no event shall CIRS assume or have any responsibility or liability for any information on this site or for any claims, damages or losses resulting from their use.
3.
CIRS reserves the right, at our discretion, to change, modify, add to, or remove portions of information on this site at any time without notice.
4.
CAS and CAS Registry Number are registered trademarks of the American Chemical Society. Any reference to such identifiers is made solely for the purpose of identifying chemical substances. GlobalCosIng is an independent platform and is not affiliated with, sponsored by, endorsed by, or an authorized partner of CAS or ACS. Based on CIRS's current review, the identifiers displayed on this platform were not obtained directly from CAS REGISTRY or any CAS subscription product or service. They were collected from governmental regulatory publications and other independent third-party sources. Users should independently verify the information before relying on it.